- BNF:
- Immune System & Malignant Disease
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- May 2016
Comments
DO NOT PRESCRIBE (DNP)6: NICE TA 389 - gemcitabine in combination with carboplatin is not recommended for treating the first recurrence of platinum-sensitive ovarian cancer.
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
search again